MyoPro 2x

Overview

The MyoPro is a myoelectric arm orthosis rather than a leg exoskeleton, a custom-fitted brace with motors at the elbow and hand that move when EMG sensors detect the wearer trying to move, which Myomo likens to power steering for the arm. It is for people with chronic arm weakness or paralysis after stroke, brachial plexus injury, brain or spinal cord injury and neuromuscular disease, who must still have detectable muscle signals and no fixed contractures. The MyoPro 2x launched on 2025-04-30 with easier independent donning, a multi-articulating wrist and standardized components, replacing the MyoPro 2+ of 2022, and Myomo says more than 3,000 patients have received a MyoPro since the original in 2012. It is a prescription device, fabricated for each patient by certified orthotics providers, and the big change for US buyers is that Medicare has covered it as a brace since 2024, with the VA and a growing list of commercial insurers also paying. FDA status is Class II registered and listed, and a CE mark is reported (unconfirmed). It sits in the same arm-and-hand niche as the soft Carbonhand glove, which helps grip rather than elbow motion.